Pharmaceutical Grade Marijuana-Europe Market Status and Trend Report 2013-2023
Report Summary
Pharmaceutical Grade Marijuana-Europe Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Pharmaceutical Grade Marijuana industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole Europe and Regional Market Size of Pharmaceutical Grade Marijuana 2013-2017, and development forecast 2018-2023
Main market players of Pharmaceutical Grade Marijuana in Europe, with company and product introduction, position in the Pharmaceutical Grade Marijuana market
Market status and development trend of Pharmaceutical Grade Marijuana by types and applications
Cost and profit status of Pharmaceutical Grade Marijuana, and marketing status
Market growth drivers and challenges
The report segments the Europe Pharmaceutical Grade Marijuana market as:
Europe Pharmaceutical Grade Marijuana Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Germany
United Kingdom
France
Italy
Spain
Benelux
Russia
Europe Pharmaceutical Grade Marijuana Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Sativex
Cesamet
Marinol
Dexanabinol
Cannabinor
Others
Europe Pharmaceutical Grade Marijuana Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Research & Academic Laboratories
Pharmaceutical & Biotechnology Companies
Hospitals
Europe Pharmaceutical Grade Marijuana Market: Players Segment Analysis (Company and Product introduction, Pharmaceutical Grade Marijuana Sales Volume, Revenue, Price and Gross Margin):
Merck
Pharmos
GW Pharmaceuticals
Valeant Pharmaceuticals International
Unimed Pharmaceuticals
Solvay Pharmaceuticals
Sanofi-Aventis
Medical Marijuana Inc
Teva Pharmaceutical
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Pharmaceutical Grade Marijuana-Europe Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Pharmaceutical Grade Marijuana industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole Europe and Regional Market Size of Pharmaceutical Grade Marijuana 2013-2017, and development forecast 2018-2023
Main market players of Pharmaceutical Grade Marijuana in Europe, with company and product introduction, position in the Pharmaceutical Grade Marijuana market
Market status and development trend of Pharmaceutical Grade Marijuana by types and applications
Cost and profit status of Pharmaceutical Grade Marijuana, and marketing status
Market growth drivers and challenges
The report segments the Europe Pharmaceutical Grade Marijuana market as:
Europe Pharmaceutical Grade Marijuana Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Germany
United Kingdom
France
Italy
Spain
Benelux
Russia
Europe Pharmaceutical Grade Marijuana Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Sativex
Cesamet
Marinol
Dexanabinol
Cannabinor
Others
Europe Pharmaceutical Grade Marijuana Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Research & Academic Laboratories
Pharmaceutical & Biotechnology Companies
Hospitals
Europe Pharmaceutical Grade Marijuana Market: Players Segment Analysis (Company and Product introduction, Pharmaceutical Grade Marijuana Sales Volume, Revenue, Price and Gross Margin):
Merck
Pharmos
GW Pharmaceuticals
Valeant Pharmaceuticals International
Unimed Pharmaceuticals
Solvay Pharmaceuticals
Sanofi-Aventis
Medical Marijuana Inc
Teva Pharmaceutical
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF PHARMACEUTICAL GRADE MARIJUANA
1.1 Definition of Pharmaceutical Grade Marijuana in This Report
1.2 Commercial Types of Pharmaceutical Grade Marijuana
1.2.1 Sativex
1.2.2 Cesamet
1.2.3 Marinol
1.2.4 Dexanabinol
1.2.5 Cannabinor
1.2.6 Others
1.3 Downstream Application of Pharmaceutical Grade Marijuana
1.3.1 Research & Academic Laboratories
1.3.2 Pharmaceutical & Biotechnology Companies
1.3.3 Hospitals
1.4 Development History of Pharmaceutical Grade Marijuana
1.5 Market Status and Trend of Pharmaceutical Grade Marijuana 2013-2023
1.5.1 Europe Pharmaceutical Grade Marijuana Market Status and Trend 2013-2023
1.5.2 Regional Pharmaceutical Grade Marijuana Market Status and Trend 2013-2023
CHAPTER 2 EUROPE MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Pharmaceutical Grade Marijuana in Europe 2013-2017
2.2 Consumption Market of Pharmaceutical Grade Marijuana in Europe by Regions
2.2.1 Consumption Volume of Pharmaceutical Grade Marijuana in Europe by Regions
2.2.2 Revenue of Pharmaceutical Grade Marijuana in Europe by Regions
2.3 Market Analysis of Pharmaceutical Grade Marijuana in Europe by Regions
2.3.1 Market Analysis of Pharmaceutical Grade Marijuana in Germany 2013-2017
2.3.2 Market Analysis of Pharmaceutical Grade Marijuana in United Kingdom 2013-2017
2.3.3 Market Analysis of Pharmaceutical Grade Marijuana in France 2013-2017
2.3.4 Market Analysis of Pharmaceutical Grade Marijuana in Italy 2013-2017
2.3.5 Market Analysis of Pharmaceutical Grade Marijuana in Spain 2013-2017
2.3.6 Market Analysis of Pharmaceutical Grade Marijuana in Benelux 2013-2017
2.3.7 Market Analysis of Pharmaceutical Grade Marijuana in Russia 2013-2017
2.4 Market Development Forecast of Pharmaceutical Grade Marijuana in Europe 2018-2023
2.4.1 Market Development Forecast of Pharmaceutical Grade Marijuana in Europe 2018-2023
2.4.2 Market Development Forecast of Pharmaceutical Grade Marijuana by Regions 2018-2023
CHAPTER 3 EUROPE MARKET STATUS AND FORECAST BY TYPES
3.1 Whole Europe Market Status by Types
3.1.1 Consumption Volume of Pharmaceutical Grade Marijuana in Europe by Types
3.1.2 Revenue of Pharmaceutical Grade Marijuana in Europe by Types
3.2 Europe Market Status by Types in Major Countries
3.2.1 Market Status by Types in Germany
3.2.2 Market Status by Types in United Kingdom
3.2.3 Market Status by Types in France
3.2.4 Market Status by Types in Italy
3.2.5 Market Status by Types in Spain
3.2.6 Market Status by Types in Benelux
3.2.7 Market Status by Types in Russia
3.3 Market Forecast of Pharmaceutical Grade Marijuana in Europe by Types
CHAPTER 4 EUROPE MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Pharmaceutical Grade Marijuana in Europe by Downstream Industry
4.2 Demand Volume of Pharmaceutical Grade Marijuana by Downstream Industry in Major Countries
4.2.1 Demand Volume of Pharmaceutical Grade Marijuana by Downstream Industry in Germany
4.2.2 Demand Volume of Pharmaceutical Grade Marijuana by Downstream Industry in United Kingdom
4.2.3 Demand Volume of Pharmaceutical Grade Marijuana by Downstream Industry in France
4.2.4 Demand Volume of Pharmaceutical Grade Marijuana by Downstream Industry in Italy
4.2.5 Demand Volume of Pharmaceutical Grade Marijuana by Downstream Industry in Spain
4.2.6 Demand Volume of Pharmaceutical Grade Marijuana by Downstream Industry in Benelux
4.2.7 Demand Volume of Pharmaceutical Grade Marijuana by Downstream Industry in Russia
4.3 Market Forecast of Pharmaceutical Grade Marijuana in Europe by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF PHARMACEUTICAL GRADE MARIJUANA
5.1 Europe Economy Situation and Trend Overview
5.2 Pharmaceutical Grade Marijuana Downstream Industry Situation and Trend Overview
CHAPTER 6 PHARMACEUTICAL GRADE MARIJUANA MARKET COMPETITION STATUS BY MAJOR PLAYERS IN EUROPE
6.1 Sales Volume of Pharmaceutical Grade Marijuana in Europe by Major Players
6.2 Revenue of Pharmaceutical Grade Marijuana in Europe by Major Players
6.3 Basic Information of Pharmaceutical Grade Marijuana by Major Players
6.3.1 Headquarters Location and Established Time of Pharmaceutical Grade Marijuana Major Players
6.3.2 Employees and Revenue Level of Pharmaceutical Grade Marijuana Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 PHARMACEUTICAL GRADE MARIJUANA MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Merck
7.1.1 Company profile
7.1.2 Representative Pharmaceutical Grade Marijuana Product
7.1.3 Pharmaceutical Grade Marijuana Sales, Revenue, Price and Gross Margin of Merck
7.2 Pharmos
7.2.1 Company profile
7.2.2 Representative Pharmaceutical Grade Marijuana Product
7.2.3 Pharmaceutical Grade Marijuana Sales, Revenue, Price and Gross Margin of Pharmos
7.3 GW Pharmaceuticals
7.3.1 Company profile
7.3.2 Representative Pharmaceutical Grade Marijuana Product
7.3.3 Pharmaceutical Grade Marijuana Sales, Revenue, Price and Gross Margin of GW Pharmaceuticals
7.4 Valeant Pharmaceuticals International
7.4.1 Company profile
7.4.2 Representative Pharmaceutical Grade Marijuana Product
7.4.3 Pharmaceutical Grade Marijuana Sales, Revenue, Price and Gross Margin of Valeant Pharmaceuticals International
7.5 Unimed Pharmaceuticals
7.5.1 Company profile
7.5.2 Representative Pharmaceutical Grade Marijuana Product
7.5.3 Pharmaceutical Grade Marijuana Sales, Revenue, Price and Gross Margin of Unimed Pharmaceuticals
7.6 Solvay Pharmaceuticals
7.6.1 Company profile
7.6.2 Representative Pharmaceutical Grade Marijuana Product
7.6.3 Pharmaceutical Grade Marijuana Sales, Revenue, Price and Gross Margin of Solvay Pharmaceuticals
7.7 Sanofi-Aventis
7.7.1 Company profile
7.7.2 Representative Pharmaceutical Grade Marijuana Product
7.7.3 Pharmaceutical Grade Marijuana Sales, Revenue, Price and Gross Margin of Sanofi-Aventis
7.8 Medical Marijuana Inc
7.8.1 Company profile
7.8.2 Representative Pharmaceutical Grade Marijuana Product
7.8.3 Pharmaceutical Grade Marijuana Sales, Revenue, Price and Gross Margin of Medical Marijuana Inc
7.9 Teva Pharmaceutical
7.9.1 Company profile
7.9.2 Representative Pharmaceutical Grade Marijuana Product
7.9.3 Pharmaceutical Grade Marijuana Sales, Revenue, Price and Gross Margin of Teva Pharmaceutical
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF PHARMACEUTICAL GRADE MARIJUANA
8.1 Industry Chain of Pharmaceutical Grade Marijuana
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF PHARMACEUTICAL GRADE MARIJUANA
9.1 Cost Structure Analysis of Pharmaceutical Grade Marijuana
9.2 Raw Materials Cost Analysis of Pharmaceutical Grade Marijuana
9.3 Labor Cost Analysis of Pharmaceutical Grade Marijuana
9.4 Manufacturing Expenses Analysis of Pharmaceutical Grade Marijuana
CHAPTER 10 MARKETING STATUS ANALYSIS OF PHARMACEUTICAL GRADE MARIJUANA
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Pharmaceutical Grade Marijuana in This Report
1.2 Commercial Types of Pharmaceutical Grade Marijuana
1.2.1 Sativex
1.2.2 Cesamet
1.2.3 Marinol
1.2.4 Dexanabinol
1.2.5 Cannabinor
1.2.6 Others
1.3 Downstream Application of Pharmaceutical Grade Marijuana
1.3.1 Research & Academic Laboratories
1.3.2 Pharmaceutical & Biotechnology Companies
1.3.3 Hospitals
1.4 Development History of Pharmaceutical Grade Marijuana
1.5 Market Status and Trend of Pharmaceutical Grade Marijuana 2013-2023
1.5.1 Europe Pharmaceutical Grade Marijuana Market Status and Trend 2013-2023
1.5.2 Regional Pharmaceutical Grade Marijuana Market Status and Trend 2013-2023
CHAPTER 2 EUROPE MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Pharmaceutical Grade Marijuana in Europe 2013-2017
2.2 Consumption Market of Pharmaceutical Grade Marijuana in Europe by Regions
2.2.1 Consumption Volume of Pharmaceutical Grade Marijuana in Europe by Regions
2.2.2 Revenue of Pharmaceutical Grade Marijuana in Europe by Regions
2.3 Market Analysis of Pharmaceutical Grade Marijuana in Europe by Regions
2.3.1 Market Analysis of Pharmaceutical Grade Marijuana in Germany 2013-2017
2.3.2 Market Analysis of Pharmaceutical Grade Marijuana in United Kingdom 2013-2017
2.3.3 Market Analysis of Pharmaceutical Grade Marijuana in France 2013-2017
2.3.4 Market Analysis of Pharmaceutical Grade Marijuana in Italy 2013-2017
2.3.5 Market Analysis of Pharmaceutical Grade Marijuana in Spain 2013-2017
2.3.6 Market Analysis of Pharmaceutical Grade Marijuana in Benelux 2013-2017
2.3.7 Market Analysis of Pharmaceutical Grade Marijuana in Russia 2013-2017
2.4 Market Development Forecast of Pharmaceutical Grade Marijuana in Europe 2018-2023
2.4.1 Market Development Forecast of Pharmaceutical Grade Marijuana in Europe 2018-2023
2.4.2 Market Development Forecast of Pharmaceutical Grade Marijuana by Regions 2018-2023
CHAPTER 3 EUROPE MARKET STATUS AND FORECAST BY TYPES
3.1 Whole Europe Market Status by Types
3.1.1 Consumption Volume of Pharmaceutical Grade Marijuana in Europe by Types
3.1.2 Revenue of Pharmaceutical Grade Marijuana in Europe by Types
3.2 Europe Market Status by Types in Major Countries
3.2.1 Market Status by Types in Germany
3.2.2 Market Status by Types in United Kingdom
3.2.3 Market Status by Types in France
3.2.4 Market Status by Types in Italy
3.2.5 Market Status by Types in Spain
3.2.6 Market Status by Types in Benelux
3.2.7 Market Status by Types in Russia
3.3 Market Forecast of Pharmaceutical Grade Marijuana in Europe by Types
CHAPTER 4 EUROPE MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Pharmaceutical Grade Marijuana in Europe by Downstream Industry
4.2 Demand Volume of Pharmaceutical Grade Marijuana by Downstream Industry in Major Countries
4.2.1 Demand Volume of Pharmaceutical Grade Marijuana by Downstream Industry in Germany
4.2.2 Demand Volume of Pharmaceutical Grade Marijuana by Downstream Industry in United Kingdom
4.2.3 Demand Volume of Pharmaceutical Grade Marijuana by Downstream Industry in France
4.2.4 Demand Volume of Pharmaceutical Grade Marijuana by Downstream Industry in Italy
4.2.5 Demand Volume of Pharmaceutical Grade Marijuana by Downstream Industry in Spain
4.2.6 Demand Volume of Pharmaceutical Grade Marijuana by Downstream Industry in Benelux
4.2.7 Demand Volume of Pharmaceutical Grade Marijuana by Downstream Industry in Russia
4.3 Market Forecast of Pharmaceutical Grade Marijuana in Europe by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF PHARMACEUTICAL GRADE MARIJUANA
5.1 Europe Economy Situation and Trend Overview
5.2 Pharmaceutical Grade Marijuana Downstream Industry Situation and Trend Overview
CHAPTER 6 PHARMACEUTICAL GRADE MARIJUANA MARKET COMPETITION STATUS BY MAJOR PLAYERS IN EUROPE
6.1 Sales Volume of Pharmaceutical Grade Marijuana in Europe by Major Players
6.2 Revenue of Pharmaceutical Grade Marijuana in Europe by Major Players
6.3 Basic Information of Pharmaceutical Grade Marijuana by Major Players
6.3.1 Headquarters Location and Established Time of Pharmaceutical Grade Marijuana Major Players
6.3.2 Employees and Revenue Level of Pharmaceutical Grade Marijuana Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 PHARMACEUTICAL GRADE MARIJUANA MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Merck
7.1.1 Company profile
7.1.2 Representative Pharmaceutical Grade Marijuana Product
7.1.3 Pharmaceutical Grade Marijuana Sales, Revenue, Price and Gross Margin of Merck
7.2 Pharmos
7.2.1 Company profile
7.2.2 Representative Pharmaceutical Grade Marijuana Product
7.2.3 Pharmaceutical Grade Marijuana Sales, Revenue, Price and Gross Margin of Pharmos
7.3 GW Pharmaceuticals
7.3.1 Company profile
7.3.2 Representative Pharmaceutical Grade Marijuana Product
7.3.3 Pharmaceutical Grade Marijuana Sales, Revenue, Price and Gross Margin of GW Pharmaceuticals
7.4 Valeant Pharmaceuticals International
7.4.1 Company profile
7.4.2 Representative Pharmaceutical Grade Marijuana Product
7.4.3 Pharmaceutical Grade Marijuana Sales, Revenue, Price and Gross Margin of Valeant Pharmaceuticals International
7.5 Unimed Pharmaceuticals
7.5.1 Company profile
7.5.2 Representative Pharmaceutical Grade Marijuana Product
7.5.3 Pharmaceutical Grade Marijuana Sales, Revenue, Price and Gross Margin of Unimed Pharmaceuticals
7.6 Solvay Pharmaceuticals
7.6.1 Company profile
7.6.2 Representative Pharmaceutical Grade Marijuana Product
7.6.3 Pharmaceutical Grade Marijuana Sales, Revenue, Price and Gross Margin of Solvay Pharmaceuticals
7.7 Sanofi-Aventis
7.7.1 Company profile
7.7.2 Representative Pharmaceutical Grade Marijuana Product
7.7.3 Pharmaceutical Grade Marijuana Sales, Revenue, Price and Gross Margin of Sanofi-Aventis
7.8 Medical Marijuana Inc
7.8.1 Company profile
7.8.2 Representative Pharmaceutical Grade Marijuana Product
7.8.3 Pharmaceutical Grade Marijuana Sales, Revenue, Price and Gross Margin of Medical Marijuana Inc
7.9 Teva Pharmaceutical
7.9.1 Company profile
7.9.2 Representative Pharmaceutical Grade Marijuana Product
7.9.3 Pharmaceutical Grade Marijuana Sales, Revenue, Price and Gross Margin of Teva Pharmaceutical
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF PHARMACEUTICAL GRADE MARIJUANA
8.1 Industry Chain of Pharmaceutical Grade Marijuana
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF PHARMACEUTICAL GRADE MARIJUANA
9.1 Cost Structure Analysis of Pharmaceutical Grade Marijuana
9.2 Raw Materials Cost Analysis of Pharmaceutical Grade Marijuana
9.3 Labor Cost Analysis of Pharmaceutical Grade Marijuana
9.4 Manufacturing Expenses Analysis of Pharmaceutical Grade Marijuana
CHAPTER 10 MARKETING STATUS ANALYSIS OF PHARMACEUTICAL GRADE MARIJUANA
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
